Capricor Therapeutics Statistics
NASDAQ: CAPRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.59+0.06 (+0.80%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Capricor Therapeutics by the numbers
Capricor Therapeutics has a market capitalization of $441.3 million based on 58.14M shares outstanding. With trailing EPS of $-2.65, Capricor Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.4% below its 50-day average and 61.2% below its 200-day average.
Average daily trading volume is 4.73M shares, or about $35.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CAPR valuation vs. peer median
| Metric | CAPR | Peer median | Difference |
|---|---|---|---|
| Market cap | $441.30M | $442.18M | -0% |
| Avg. volume | 4.73M | 461.66K | +925% |
Peer median across 8 companies: AQST, LYEL, INDP, CTMX, EOLS, AMRN, DMAC, KMDA.
Valuation
- Market cap
- $441.30M
- EPS (TTM)
- $-2.65
- Shares outstanding
- 58.14M
Price and trading
- Previous close
- 7.53
- Open
- 8.16
- Day range
- 7.38 – 8.34
- 52-week range
- 2.96 – 40.37
- 52-week change
- +32.00%
- Beta
- —
- Volume
- 10.65M
- Average volume
- 4.73M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 441.30M
- Forward Pe
- -5.30
- Eps
- -2.65
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 40.37
- Week52 Low
- 2.96
- Avg Volume
- 4.73M
- Shares Outstanding
- 58.14M
- Ma50
- 8.02
- Ma200
- 19.57
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -81.20%
- Pct From52w Low
- 156.42%